Discover
CRDF
Cardiff Oncology, Inc.
1.37
2 x 0.92
2 x 1.71
bid
ask
+
0.07
5.38%
2 @ 04:00 PM
1.39 +0.02 (1.46%)
| Ytd | -51.25% | |
| 1y | -36.57% |
1.28
day range
1.39
0.76
52 week range
3.31
| Open | 1.29 | Prev Close | 1.30 | Low | 1.28 | High | 1.39 | Mkt Cap | 106.58M |
| Vol | 742.26K | Avg Vol | 1.24M | EPS | -0.60 | P/E | N/A | Forward P/E | -4.03 |
| Beta | 1.93 | Short Ratio | 8.06 | Inst. Own | 27.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 1.01 | 200-d Avg | 1.68 | 1yr Est | 10.75 |
| Income Statement | |||
| Total Revenue | 104.00K | ||
| Revenues (USD) | 104.00K | ||
| Gross Profit | 104.00K | ||
| Operating Expenses | 9.72M | ||
| Research and Development Expense | 5.92M | ||
| Selling, General and Administrative Expense | 3.80M | ||
| Operating Income | -9.61M | ||
| Net Income | -9.23M | ||
| Net Income Common Stock | -9.24M | ||
| Net Income Common Stock (USD) | -9.24M | ||
| Consolidated Income | -9.23M | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -9.23M | ||
| Earning Before Interest & Taxes (USD) | -9.23M | ||
| Preferred Dividends Income Statement Impact | 6.00K | ||
| Weighted Average Shares | 68.40M | ||
| Weighted Average Shares Diluted | 68.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.20M | ||
| Cash and Equivalents (USD) | 9.20M | ||
| Investments | 25.32M | ||
| Investments Current | 25.32M | ||
| Trade and Non-Trade Receivables | 189.00K | ||
| Current Assets | 35.59M | ||
| Property, Plant & Equipment Net | 810.00K | ||
| Total Assets | 37.33M | ||
| Debt Current | 457.00K | ||
| Total Debt | 457.00K | ||
| Current Liabilities | 10.80M | ||
| Total Liabilities | 10.80M | ||
| Accumulated Retained Earnings (Deficit) | -451.61M | ||
| Accumulated Other Comprehensive Income | -62.00K | ||
| Shareholders Equity | 26.53M | ||
| Shareholders Equity (USD) | 26.53M | ||
| Assets Non-Current | 1.74M | ||
| Total Debt (USD) | 457.00K | ||
| Trade and Non-Trade Payables | 3.99M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 222.00K | ||
| Net Cash Flow from Financing | 149.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 653.00K | ||
| Capital Expenditure | -44.00K | ||
| Issuance (Purchase) of Equity Shares | 213.00K | ||
| Net Cash Flow from Investing | 12.27M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 12.31M | ||
| Net Cash Flow from Operations | -11.76M | ||
| Share Based Compensation | 920.00K | ||